Keywords: sb, coulter, refile, bexxar, application, smithkline, beecham

SB, Coulter refile US Bexxar application

Article | 19 September 2000

SmithKline Beecham and Coulter have refiled their Biologics LicenseApplication in the USA for Bexxar (tositumomab) as a treatment for patients ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Drugs

Bexxar

Tositumomab and Iodine 1131 Tositumomab

Ibritumomab Tiuxetan

Zevalin

Go to drug listing